Carol Zhou is Senior Vice President, Head of Medical Beauty & Business Development at Shiseido China, and Managing Director of Ziyue Fund. Her career spans the United States, Asia-Pacific and China, combining brand leadership with business building and investment.

At Shiseido, Zhou spearheaded the development of RQ PYOLOGY, Shiseido's first medical beauty brand, bringing together skincare, professional treatments and ongoing skin management. She also helped establish Shiseido's China-focused beauty investment fund and serves on the board of recombinant collagen company Trautec, Shiseido's first investment in a Chinese company.

Previously, Zhou held leadership roles at Burberry, Marriott, L'Oréal and Unilever across North America, Asia-Pacific and Greater China.

Her work focuses on anticipating changes in consumer behavior and translating those insights into new businesses, brand strategies and partnerships that create lasting value.